# LAUNCHCYTE LLC: Form D filings

LAUNCHCYTE LLC, a biotechnology company in Pittsburgh, PA, filed 10 Form D notices with the SEC between 2009 and 2014. The latest, on January 28, 2014, reports an offering of $1 million with nothing sold yet.

Find out what LAUNCHCYTE LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20LAUNCHCYTE%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=LAUNCHCYTE%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Flaunchcyte-llc-1125594)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20LAUNCHCYTE%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=LAUNCHCYTE%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Flaunchcyte-llc-1125594)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pennsylvania](https://specstream.ai/data/form-d/state/pennsylvania): 987 rows, by operating companies, filed since November 1, 2024, $49.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/pennsylvania
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2403 SIDNEY ST, STE 270, Pittsburgh, PA, 15203
- Phone: (412) 481-2200
- Industry: Biotechnology
- Entity type: Limited Liability Company
- Incorporated in: Pennsylvania
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1125594

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 28, 2014 | New notice | $1,000,000 | $0 | $1,000,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1125594/000089843214000076/0000898432-14-000076-index.htm) |
| Apr 24, 2012 | New notice | $750,000 | $0 | $750,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1125594/000089843212000520/0000898432-12-000520-index.htm) |
| Jun 2, 2011 | New notice | $1,575,000 | $1,055,000 | $520,000 | 6 | May 19, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1125594/000112559411000001/0001125594-11-000001-index.htm) |
| Oct 12, 2010 | Amendment | $607,341 | $493,697 | $113,644 | 8 | Sep 20, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1125594/000112559410000005/0001125594-10-000005-index.htm) |
| Sep 30, 2010 | New notice | $607,341 | $379,026 | $228,315 | 7 | Sep 20, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1125594/000112559410000004/0001125594-10-000004-index.htm) |
| Jun 15, 2010 | Amendment | $1,150,000 | $926,720 | $223,280 | 11 | Jun 9, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1125594/000112559410000003/0001125594-10-000003-index.htm) |
| Jan 6, 2010 | Amendment | $1,150,000 | $776,720 | $373,280 | 8 | Jun 9, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1125594/000112559410000002/0001125594-10-000002-index.htm) |
| Jan 6, 2010 | Amendment | $1,021,293 | $1,021,293 | $0 | 2 | Dec 18, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1125594/000112559410000001/0001125594-10-000001-index.htm) |
| Dec 31, 2009 | New notice | $229,720 | $229,720 | $0 | 2 | Dec 18, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1125594/000112559409000004/0001125594-09-000004-index.htm) |
| May 28, 2009 | New notice | $1,150,000 | $0 | $1,150,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1125594/000112559409000003/0001125594-09-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Michael A. Turpin | Director |  |
| Adam W. Verost | Director |  |
| Thomas Petzinger | Executive Officer, Director |  |
| Gregory T. Hebrank | Director |  |
| Barbara A. Carryer | Director |  |
| Robert A. Unkovic | Director |  |
| William A. Mitchell | Director |  |

## Other biotechnology companies in Pennsylvania that filed recently

- [Traws Pharma, Inc.](https://specstream.ai/data/form-d/company/traws-pharma-inc-1130598) offering · Nov 5, 2026
- [BioLattice Ophthalmics, Inc,](https://specstream.ai/data/form-d/company/biolattice-ophthalmics-inc-2125596) $1.8 million · Oct 28, 2026
- [Myris Therapeutics, Inc.](https://specstream.ai/data/form-d/company/myris-therapeutics-inc-1924725) $500,000 · Oct 14, 2026
- [Praeventix, Inc.](https://specstream.ai/data/form-d/company/praeventix-inc-1952974) $5.6 million · Sep 10, 2026
- [Plowshare Therapies LLC](https://specstream.ai/data/form-d/company/plowshare-therapies-llc-2152111) $6.7 million · Aug 31, 2026
- [Noveome Biotherapeutics, Inc.](https://specstream.ai/data/form-d/company/noveome-biotherapeutics-inc-1478304) $6.8 million · Aug 27, 2026

[Every Form D from the week of Jan 27, 2014](https://specstream.ai/data/form-d/week/2014-01-27) · [All recent filings in Pennsylvania](https://specstream.ai/data/form-d/state/pennsylvania) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what LAUNCHCYTE LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).